Physician

Ashok Cherian Jacob, M.D, MPH

According to 2025 Medicare claims, Ashok Jacob, M.D, MPH (NPI: 1467676759) practices rheumatology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Anne Arundel, MD. This provider's primary affiliated billing organization is ANNAPOLIS RHEUMATOLOGY LLC (NPI: 1104188424; TIN: 45-4290699) and primary practice location at 21401-8922.

Jacob's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 373 traditional Medicare patients, billed 195,820 HCPCS/CPT codes, and received $3,384,281 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,599 prescription claims across 266 beneficiaries totaling $2,145,566 in drug costs, led by Rinvoq (Upadacitinib). Open Payments data shows 157 records totaling $3,210. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $958,227 to $3,384,281. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $470,651 to $2,145,566. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	591	156,212	$958,227
2016	480	154,216	$981,359
2017	500	167,460	$1,253,618
2018	516	188,779	$1,992,765
2019	499	196,260	$2,684,840
2020	448	254,551	$2,982,747
2021	461	250,573	$2,846,894
2022	467	234,267	$3,037,483
2023	394	215,444	$2,806,556
2024	373	195,820	$3,384,281

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	240	1,710	$470,651
2016	228	1,703	$798,912
2017	259	2,002	$903,636
2018	273	1,997	$987,300
2019	264	1,907	$1,314,413
2020	249	1,909	$1,460,671
2021	292	2,026	$1,993,723
2022	297	1,940	$2,022,600
2023	263	1,717	$2,024,294
2024	266	1,599	$2,145,566

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	59	334	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	262	488	$92
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	110	826	$60
76882	Limited ultrasound scan of joint or other extremity structure except blood vessels	58	58	$51
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	202	337	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rinvoq	Upadacitinib	38	1,860	$388,793
Enbrel Sureclick	Etanercept	34	1,260	$318,587
Xeljanz Xr	Tofacitinib Citrate	33	990	$184,081
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	14	420	$175,176
Humira(Cf) Pen	Adalimumab	22	616	$149,854

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	157	$3,210	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ashok Cherian Jacob, M.D, MPH?

Tedicare shows public-source Medicare data for Ashok Cherian Jacob, M.D, MPH (NPI 1467676759), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ashok Cherian Jacob, M.D, MPH have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ashok Cherian Jacob, M.D, MPH?

Ashok Cherian Jacob, M.D, MPH is linked to ANNAPOLIS RHEUMATOLOGY LLC (billing NPI 1104188424) in the available physician profile data.

Does Ashok Cherian Jacob, M.D, MPH have Open Payments data?

Ashok Cherian Jacob, M.D, MPH has 157 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.